openPR Logo
Press release

Drug Delivery Devices Market Surges Towards a $24.65 Billion Valuation by 2030

03-21-2024 02:20 PM CET | Health & Medicine

Press release from: Meticulous Research®

Meticulous Research®-a leading market research company, published a research report titled, 'Drug Delivery Devices Market by Product (Nebulizer, Inhaler, Syringe, Transdermal Patch, Drop Bottle, Pen Injector, Implantable Device), Therapeutic Area (Diabetes, Infectious, Oncology, Respiratory, Cardiovascular, Autoimmune) - Global Forecast to 2030'
According to this latest publication from Meticulous Research®, the drug delivery devices market is projected to reach $24.65 billion by 2030, at a CAGR of 7.6% from 2023 to 2030. The growth of the drug delivery devices market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in disease treatment approaches, growing R&D expenditure in pharmaceutical and biotechnology industries, and the increasing demand for advanced drug delivery systems. Factors such as emerging economies and technological advancements in drug delivery systems are a few of the opportunities that would help grow the market in the future.

Factors such as biocompatibility and acceptability could be considered a challenge for the drug delivery devices market. However, manufacturing defects and the lack of awareness and education about newer drug delivery systems restrain the growth of the market.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5742

Key Players
The key players profiled in the drug delivery devices market report are Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), GMP Laboratories of America, Inc. (U.S.), Gemini Pharmaceuticals, Inc. (U.S.), Resyca GmbH (Netherlands), Novartis International AG (Switzerland), Becton, Dickinson, and Company (U.S.), Lifelong Meditech Private Limited (India), Bright Pharma Caps, Inc. (U.S.), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Eclam Medical ACS Ltd. (Israel), SMC Ltd. (U.S.), Owen Mumford Limited (U.K.), Haselmeier GmbH (Germany), SHL Medical AG (Switzerland), Ypsomed Holding AG (Switzerland), AptarGroup, Inc. (U.S.), Kindeva Drug Delivery L.P. (U.S.), Nemera Group (France), and Recipharm AB (Sweden).

Browse Here:
https://www.meticulousresearch.com/product/drug-delivery-devices-market-5742

The drug delivery devices market is segmented by Product (Nasal & Pulmonary Drug Delivery Systems [Nebulizers {Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers}, Empty Inhalers {Metered-Dose Inhalers, Soft Mist Inhalers, Dry Powder Inhalers}, Steamers, Nasal Sprays], Parenteral Drug Delivery Systems [Syringes {Conventional Syringes, Safety Syringes, Prefilled Syringes}, Pen Injectors, Autoinjectors, Needle Free Injectors, Wearable Injectors/On-Body Drug Delivery System], Topical & Transdermal Drug Delivery Systems [Transdermal Patches, Wearable Patches], Drop Bottle Drug Delivery Systems [Nasal Drop Bottles, Ocular Drop Bottles, Cochlear Drop Bottles], Implantable Drug Delivery Devices [Inserts, Pumps, Drug Eluting Stents], Insulin Pumps, Intrauterine Devices, Infusion Pumps), Therapeutic Areas (Diabetes, Infectious Diseases, Oncology, Cardiovascular Diseases, Respiratory Diseases, Neurological Disorders, Autoimmune Diseases) and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Quick Buy: https://www.meticulousresearch.com/Checkout/60230508

Scope of the Report:
Drug Delivery Devices Market, by Product
• Nasal & Pulmonary Drug Delivery Systems
o Nebulizers
 Jet Nebulizers
 Ultrasonic Nebulizers
 Mesh Nebulizers
o Empty Inhalers
 Metered-Dose Inhalers
 Soft Mist Inhalers
 Dry Powder Inhalers
o Steamers
o Nasal Sprays
• Parenteral Drug Delivery Systems
o Syringes
 Conventional Syringes
 Safety Syringes
 Prefilled Syringes
o Pen Injectors
o Autoinjectors
o Needle Free Injectors
o Wearable Injectors/On-Body Drug Delivery System
• Topical & Transdermal Drug Delivery Systems
o Transdermal Patches
o Wearable Patches
• Drop Bottles Drug Delivery Systems
o Nasal Drop Bottles
o Ocular Drop Bottles
o Cochlear Drop Bottles
• Implantable Drug Delivery Devices
o Inserts
o Pumps
o Drug Eluting Stents
• Insulin Pumps
• Intrauterine Devices
• Infusion Pumps
Drug Delivery Devices Market, by Therapeutic Area
• Diabetes
• Infectious Diseases
• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• Neurological Diseases
• Autoimmune Diseases

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5742

Key questions answered in the report:
• Which are the high-growth market segments in terms of drug delivery devices by product, therapeutic area, and geography?
• What was the historical market for drug delivery devices across the globe?
• What are the market forecasts and estimates for the period 2023-2030?
• What are the major drivers, restraints, opportunities, and challenges in the drug delivery devices market?
• Who are the major players operating in the drug delivery devices market?
• What is the competitive landscape like, and who are the leaders in the drug delivery devices market?
• What are the recent developments in the drug delivery devices market?
• What are the different strategies adopted by the major players in the drug delivery devices market?
• What are the geographical trends and high-growth regions/countries?

𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 :

https://www.meticulousresearch.com/speak-to-analyst/cp_id=5742

ContactUs:
MeticulousResearch®
Email- sales@meticulousresearch.com
ContactSales-+1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Devices Market Surges Towards a $24.65 Billion Valuation by 2030 here

News-ID: 3439667 • Views:

More Releases from Meticulous Research®

Global Antiviral & Antimicrobial Coatings Market Analysis 2026-2036: Trends, Applications, and Growth Forecast
Global Antiviral & Antimicrobial Coatings Market Analysis 2026-2036: Trends, App …
The antiviral and antimicrobial coatings market has seen remarkable growth in recent years, reflecting the world's heightened focus on hygiene and disease prevention. In 2025, the market was valued at around USD 6.4 billion, and it is projected to reach nearly USD 18.94 billion by 2036, expanding at an annual growth rate of 10.5%. This growth is being driven by several factors, including the rising occurrence of healthcare-associated infections, increasing
Global Activated Alumina Market Outlook 2026-2036: Growth, Trends, Applications, and Regional Analysis
Global Activated Alumina Market Outlook 2026-2036: Growth, Trends, Applications, …
The global activated alumina market has experienced steady growth over the past several years and is expected to continue on a positive trajectory in the coming decade. Valued at USD 1.2 billion in 2025, the market is projected to reach USD 1.3 billion in 2026 and expand to approximately USD 2.22 billion by 2036, representing a compound annual growth rate of 5.5% from 2026 to 2036. This growth is largely
Global Adaptogenic Beverages Market Analysis 2026-2036: Trends, Growth Drivers, and Regional Insights
Global Adaptogenic Beverages Market Analysis 2026-2036: Trends, Growth Drivers, …
The global adaptogenic beverages market has been experiencing significant growth, driven by the rising consumer focus on holistic wellness and the expanding functional food and beverage industry. Valued at approximately USD 1.18 billion in 2025, the market is projected to reach around USD 2.89 billion by 2036, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2036. This growth is fueled by consumers' increasing desire to
Europe Pet Food Protein Ingredients Market Analysis 2026-2036: Trends, Growth Drivers, and Future Outlook
Europe Pet Food Protein Ingredients Market Analysis 2026-2036: Trends, Growth Dr …
The Europe pet food protein ingredients market has been witnessing steady growth over the past few years, driven primarily by an increase in pet ownership across the region, the humanization of pets, and a rising demand for premium and specialized pet food products. In 2025, the market was valued at approximately USD 2.55 billion and is projected to grow to about USD 4.72 billion by 2036. The market is expected

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase